MedTrace Logo

Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding

NCT04748393 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2021-02-10

No results posted yet for this study

Summary

This study is an international, multicenter, academically sponsored, observational study, that focusses on fertile female patients with proven symptomatic deep vein thrombosis of the legs (DVT) or acute pulmonary embolism (PE). The incidence and severity of abnormal menstrual bleeding will be assessed for each menstrual period and correlated to quality of life. Causes of abnormal menstrual bleeding other than active anticoagulant treatment will be assessed. Treatment of abnormal menstrual bleeding (all within routine clinical care) will be evaluated for efficacy and safety.

Conditions

  • Venous Thromboembolism

Sponsors & Collaborators

  • Leiden University Medical Center

    lead OTHER

Principal Investigators

  • F.A. Klok · LUMC Leiden

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2021-02-01
Completion
2021-02-01

Countries

  • Austria
  • France
  • Germany
  • Netherlands
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04748393 on ClinicalTrials.gov